Canada Periodontal Therapeutics Market Size & Outlook

The periodontal therapeutics market in Canada is expected to reach a projected revenue of US$ 72.3 million by 2030. A compound annual growth rate of 8% is expected of Canada periodontal therapeutics market from 2024 to 2030.
Revenue, 2023 (US$M)
$42.5
Forecast, 2030 (US$M)
$72.3
CAGR, 2024 - 2030
8%
Report Coverage
Canada

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada periodontal therapeutics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada periodontal therapeutics market highlights

  • The Canada periodontal therapeutics market generated a revenue of USD 42.5 million in 2023 and is expected to reach USD 72.3 million by 2030.
  • The Canada market is expected to grow at a CAGR of 8% from 2024 to 2030.
  • In terms of segment, chronic periodontal disease was the largest revenue generating type in 2023.
  • Chronic Periodontal Disease is the most lucrative type segment registering the fastest growth during the forecast period.


Periodontal therapeutics market data book summary

Market revenue in 2023USD 42.5 million
Market revenue in 2030USD 72.3 million
Growth rate8% (CAGR from 2024 to 2030)
Largest segmentChronic periodontal disease
Fastest growing segmentChronic Periodontal Disease
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Other Types
Key market players worldwidePfizer Inc, Lupin, Teva Pharmaceutical Industries Ltd ADR, Sun Pharmaceutical Industries, Tokyo Chemical Industry, Bausch Health Companies Inc, Melinta Therapeutics, Cipla Ltd DR, Chartwell Pharmaceuticals


Other key industry trends

  • In terms of revenue, Canada accounted for 4.9% of the global periodontal therapeutics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. periodontal therapeutics market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 72.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Periodontal Therapeutics Market Companies

Name Profile # Employees HQ Website
Chartwell Pharmaceuticals View profile 101-250 Congers, New York, United States, North America https://chartwellpharma.com/
Melinta Therapeutics View profile 101-250 New Haven, Connecticut, United States, North America http://melinta.com
Tokyo Chemical Industry View profile 501-1000 Chennai, Tamil Nadu, India, Asia https://www.tcichemicals.com/
Bausch Health Companies Inc View profile 20270 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 https://www.bauschhealth.com
Teva Pharmaceutical Industries Ltd ADR View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Sun Pharmaceutical Industries View profile 10001+ Mumbai, Maharashtra, India, Asia http://www.sunpharma.com
Lupin View profile 10001+ Mumbai, Maharashtra, India, Asia https://www.lupin.com
Cipla Ltd DR View profile 38955 Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 https://www.cipla.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com

Canada periodontal therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to periodontal therapeutics market will help companies and investors design strategic landscapes.


Chronic periodontal disease was the largest segment with a revenue share of 37.65% in 2023. Horizon Databook has segmented the Canada periodontal therapeutics market based on gingivitis, chronic periodontal disease, aggressive periodontal disease, other types covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Canada periodontal therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada periodontal therapeutics market databook

  • Our clientele includes a mix of periodontal therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada periodontal therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Canada periodontal therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada periodontal therapeutics market size, by type, 2018-2030 (US$M)

Canada Periodontal Therapeutics Market Outlook Share, 2023 & 2030 (US$M)

Canada periodontal therapeutics market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online